GlobeNewsWire
09 Mar 2026, 20:01 UTC · 29w ago
Verdict
Headline takes no side. We score VYGR +0.80 — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 35% of relationship scores this week
[mutual] Voyager advances programs with partners including AstraZeneca Rare Disease.
More positive than 35% of relationship scores this week
[mutual] Voyager is advancing programs with Neurocrine Biosciences, including a partnered program in FA.
More positive than 35% of relationship scores this week
[mutual] Voyager is advancing gene therapy programs under licenses and collaboration with Novartis.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
19h ago
−40.4%
Price is moving against the score
$2.45 vs $4.11 close before publication (Mar 9) · not market-adjusted
VYGR chart →
